Evaluation of anti-allergic and anti-anaphylactic activity of ethanolic extract of Zizyphus jujuba fruits in rodents

Abstract

The present study reports the anti-allergic activity of ethanolic extract of Zizyphus jujuba Mill., Rhamnaceae, and its possible mode of action. The effect of extract of Z. jujuba at different doses (250, 500 and 1000 mg/kg, orally) was simulated on studied animal models of asthma and allergy: a) milk induced eosinophilia and leukocytosis; b) compound 48/80 induced mast cell degranulation; and, c) active and passive cutaneous anaphylaxis. In addition, extract of Z. jujuba's effect on sensitized guinea pig ileum (ex vivo) and tracheal chain preparations (in vitro) were investigated.Treatment with extract of Z. jujuba at all doses significantly: prevented the milk-induced eosinophilia and compound 48/80 induced degranulation of mesenteric mast cells; decreased passive cutaneous and active anaphylactic reactions. In addition, extract of Z. jujuba inhibited acetylcholine as well as histamine induced tracheal chain contraction, and also antigen induced contraction of sensitized guinea pig ileum (Shultz-Dale inhibition test). Furthermore, it exhibited also free radicals scavenging activity (in vitro). The observed anti-allergic and anti-anaphylactic activity of extract of Z. jujuba may be largely through the stabilization of mast cells by the membrane presence of phytoconstituents (steroidal saponins and flavonoids).

Anti-allergic activity; Eosinophilia; Hypersensitivity reaction; Mast cell degranulation; Zizyphus jujuba

Introduction

The allergy is an immune disease origin which includes asthma, rhinitis, atopic eczema and dermatitis syndrome (Xie and He, 2005). Anaphylaxis is a hyper response to antigen cross-linking of IgE bound to mast cells, its causes degranulation leading to the release of mediators such as histamine, prostaglandins and later on, proteases, leukotrienes and several pro-inflammatory and chemotactic cytokines (Kalesnikoff and Galli, 2008) triggering smooth muscle contraction, vasodilatation, increased vascular permeability and mucous hyper secretion (Cavalher-Machado et al., 2008).

Zizyphus jujuba Mill, called as Red date, Chinese date, and Bera (Pushto) belongs to family Rhamnaceae which constitute fifty genera and more than 900 species. The Z. jujuba fruit has been described to the ''fruit of life" and used in traditional Chinese medicine. In addition, it is also used in the treatment of various physiological functions of the body viz. digestive disorders, weakness, urinary tract infections, diabetes, skin infections, loss of appetite, fever, pharyngitis, bronchitis, anemia, hyperlipidemia, and diarrhea (Bown, 1995; Him-Che, 1985). The fresh leaves of Z. mauritiana L (one of the species) are used in jaundice (Gul et al., 2009), and it contains therapeutically active phytochemicals, vitamin C, phenolic compounds, flavonoids, triterpenic acids, and polysaccharides. Documented reports of jujuba fruits also shown to produce anti-inflammatory, anti-obesity, immune-stimulating, antioxidant, gastrointestinal and hepatoprotective effect and inhibit foam cell formation in macrophages (Gao et al., 2013) and jujuba containing herbal formulation found to exhibit anticancer activity (Saif et al., 2010).

Z. jujuba grows in Ahamadnagar, Maharashtra State and commonly called the Indian date and fruits of this plant are edible and used for the treatment of various diseases such as pharyngitis, bronchitis, inflammation, liver diseases, and skin infections by local tribal people. Although, Z. jujuba is traditionally used for allergy disorder, there is no scientific data available on allergy related disorders. Therefore, objective of the study was evaluation of anti-allergic and anaphylactic activity of ethanolic extract of Zizyphus jujuba fruit in animals models and in-vitro condition and also to understand its mode of action.

Materials and methods

Animals

Wistar rats (150-200 g), Swiss albino mice (20-25 g), Dunkin-Hartley guinea pigs (350-400 g) of either sex were purchased from Indian Toxicological Institute, Pune. Animals were maintained in our animal house under conditions [temperature (24 ± 1ºC), relative humidity (45-55%), light (12 h) and dark (12 h) cycle] and free access to ready-made food pellets and water ad libitum. The experimental protocols were approved by the Institutional Animal Ethics Committee (SCOP/IAEC/Approval/2008-09/13).

Drugs, chemicals and reagents

Compound 48/80 (Sigma Aldrich, USA), histamine hydrochloride (Analab Fine Chemicals, Mumbai), egg albumin (Loba Chemie, Mumbai), horse serum (Serum Institute of India Ltd., Pune) and other drugs, dexamethasone, ketotifen fumerate (Cipla Healthcare Ltd., India) were procured.

Preparation of ethanolic extract of Z. jujuba fruits (EEZJ)

The fruits of Zizyphus jujuba Mill, Rhamnaceae, were collected in the month of December from local supplier, Pune. The plant materials was authenticated in the Botany Department of Agharkar Research Institute, Pune, Maharashtra India (voucher specimen number, Auth. 09-02) and deposited. The fruits were shade dried, powdered and sieved through 40# mesh. The dried powder (1000 g) of fruits was extracted by cold maceration for 72 h with ethanol (95%). The ethanolic extract was filtered and concentrated in rotary vacuum evaporator to yield semi solid extract (yield-7.13% w/w) and preserved at 10ºC.

Phytochemical analysis of EEZJ

The phytochemical analysis of EEZJ for the presence of alkaloid, saponins, flavonoids, tannins and proteins and spectral studies, FT-IR and UV were performed.

Thin layer chromatography of EEZJ

TLC was performed on pre-coated plates of silica gel 60 F254 (Merck) using solvent system (benzene:ethyl acetate:formic acid, 36:12:5). The phytoconstituents separated on chromatographic plate by running reference compounds (Betulinic acid, oleanolic acid, betulin and lupeol) were identified by spraying the mixture of anisaldehyde and sulfuric acid and scanned at 314 nm and spotted.

Drug preparation

Dexamethasone, ketotifen fumerate, ibuprofen and EEZJ were freshly prepared as 1% w/v suspension uniform incarboxy methyl cellulose (CMC) prior to administration.

Acute toxicity study

Acute toxicity of EEZJ was performed by oral route in mice as per OECD guidelines 423.

Anti-allergic activity evaluation

Effect of EEZJ on milk-induced leukocytosis and eosinophilia in mice

Swiss albino mice (20-25 g) were randomly divided into five groups (6/group). Group-I received CMC (10 ml/kg, p.o.), administered group II boiled and cooled milk [4 ml/kg, subcutaneously (s.c.)] and groups, III, IV, V and VI received EEZJ (250, 500 and 1000 mg/kg, p.o.) and dexamethasone (0.27 mg/kg, i.p.) respectively. One hour later, all groups of mice received boiled and cooled milk (4 ml/kg, s.c.). Blood samples were collected before and 24 h after milk administration from retroorbital plexus, under light ether anesthesia and full eosinophils and leukocytes were counted (Bhargava and Singh, 1981).

Passive cutaneous anaphylaxis in rats

Rats were sensitized with 100 µg of egg albumin (EA) adsorbed on 12 mg of aluminum hydroxide (adjuvant) s.c. on 1^st, 3^rd and 5^th day. On 11^th day, the blood samples were collected and serum was separated. The rats were randomly divided into five groups (6/group). The rat homologous antiserum (100 µl) was injected s.c. into the shaved dorsal skin of rats. After 24 h, group I (induced control) received CMC suspension (1% w/v 10 ml/kg, p.o.), group II, III, and IV received EEZJ (250, 500 and 1000 mg/kg, p.o., respectively) and group V dexamethasone (0.27 mg/kg, i.p.). The rats of all groups were injected intravenously with 0.5 ml of solution containing mixture (1:1) of Evan's blue (0.5% w/v) and EA (100 µg) via tail vein, 30 min after the drug/extract treatment. Area of leakage of the blue dye was measured with the help of Vernier Caliper and expressed as mm² (Gautam et al., 1989).

Effect of EEZJ on serum IgE in rats

The sensitized rats by the procedure described earlier were randomly divided into four groups (6/group): Group I (induced control) received orally CMC; group II and III, received EEZJ 500 and 1000 mg/kg, orally respectively and group IV dexamethasone (0.27 mg/kg, i.p.) from 4^th day onwards up to 10^th day. The blood samples of sensitized rats were collected on 6^th, 8^th and 11^th day and serum IgE was assayed.

Serum IgE was determined by sandwich ELISA using anti-rat IgE antibody to capture reagent, and biotinconjugated anti-rat IgE antibody as detection reagent. Thereafter, peroxidase conjugated extravidin and OPD-H₂O₂ were added. IgE standard used in the concentration range of 0.15- 20 ng/ml and samples were diluted to between 1/20 and 1/200. The relative concentration of anti-egg albumin IgE was calculated by comparing with the pooled serum sample of diluted egg albumin-immunized rats to which 10 AU/ml were assigned.

Active anaphylaxis in rats

Thirty rats were sensitized by injecting (s.c.) 0.5 ml of horse serum/rat. Sensitized rats were randomly divided into five groups (6/group). Group II served the induced control received CMC (10 ml/kg, p.o.). Groups III, IV and V were administered EEZJ (250, 500 and 1000 mg/kg, p.o.) respectively, and group VI with dexamethasone (0.27 mg/kg, i.p.) daily for ten days. Group I did not receive any treatment and served the usual control. On 10^th day, 2 h after the treatment, the rats were challenged with 0.25 ml (diluted 1:1 in standard saline) horse serum/rat by intravenous injection. The symptoms of anaphylactic reactions like respiratory distress, increased respiratory rate, dyspnoea, cyanosis and mortality were recorded. The severities of anaphylactic reactions were respiratory scored on a scale (0-20). The scoring system was: increased respiratory rate (2), dyspnea for 10 min. (4), dyspnea and cyanosis for 10 min (8) and respiratory collapse and death (12) (Mitra et al., 1999).

Histamine induced paw edema

Rats were divided into five groups (6/group) and treated with EEZJ (500 and 1000 mg/kg, p.o.) and ibuprofen (50 mg/kg, p.o.) and vehicle control (CMC, p.o.). Normal control group did not receive any treatment. The EEZJ and ibuprofen were administered 30 min prior to the injection of 0.1 ml histamine (1% w/v) into the planter region of the right paw of each rat (Holsapple et al., 1980). The paw volume was measured prior, at 2 and 3 h using plethysmometer (Orchid scientifics, Nashik).

Effect of EEZJ on compound 48/80 induced mast cell degranulation in rats

Thirty rats were sensitized with compound 48/80 (1 mg/kg, s.c.).The sensitized rats were randomly divided into five groups (6/group). Group II induced control, and received (CMC, p.o.). Group II, III, IV received EEZJ (250, 500 and 1000 mg/kg, p.o., respectively) and group V ketotifen fumerate (1 mg/kg, i.p.), daily for seven days. Group I normal untreated control. On the 7^th day, rats were injected (i.p.) 10 ml cold phosphate buffered saline. After a gentle abdominal massage, animals were sacrificed; the peritoneal fluid was collected and transferred into siliconized test tube containing 7-10 ml of phosphate buffer (pH 7.4). Mast cell viability was checked by Trypan blue dye (0.4%) exclusion test. Mast cells were purified by percoll density centrifugation method. The pellets of mast cells were resuspended in phosphate buffer solution and incubated with compound 48/80 (5 µg/ml) at 37ºC for 10 min. After incubation, cells were centrifuged and stained with Toluidine blue (0.1%). Degranulated and intact mast cells were counted under high power microscopy and percent degranulation was calculated (Andhare et al., 2012).

Effect of EEZJ on histamine induced contraction of isolated guinea pig ileum preparation

Fasted guinea pigswere sacrificed and ileum was isolated and mounted in an organ bath containing Tyrode solution, aerated at 37 ± 0.5ºC and dose response curves of histamine was studied in the presence and absence of EEZJ and chlorpheniramine maleate and IC₅₀ was calculated.

Shultz-Dale inhibition test

Male guinea pigs were sensitized with EA (10 mg/kg, i.p.) on the 1^st and 3^rd day. On the 14^th day, guinea pigs were sacrificed and isolated ileal strip from each animal, suspended in an organ bath containing aerated Tyrode solution at 37ºC. Tissue sensitivity was tested with histamine (0.05 µg/ml). EA (10 µg/ml) was added and responses were recorded for 90 s on a Sherrington's rotating drum. Various concentration of EEZJ (10-150 µg/ml) and disodium cromoglycate (5-10 µg/ml) were added to bath prior to EA and contraction of ileal strips were recorded. The control group induced ileum contraction with EA (10 µg/ml) was 100% considered and compared with contraction of ileum with the test groups (sensitized and treated with EEZJ and disodium cromoglyacate). The percent inhibition of ileum contraction was calculated.

Effect of EEZJ on guinea pig tracheal chain preparation

Guinea pig trachea was cut into individual rings and tied together in series to form a chain. Tracheal chain was suspended in Kreb's solution, aerated at 37ºC and response curve of acetylcholine (Ach) was studied in the presence and absence of atropine and EEZJ maleate and IC₅₀ was calculated (Chaudhari and Lahiri, 1974).

Statistical analysis

The mean ± SEM values were calculated for each group. Analysis of variance (ANOVA) followed by Tukey-Kramer multiple comparisons test was used for statistical analysis. Values of p < 0.05 were considered statistically significance. IC₅₀ values were calculated by the method of Litchfield and Wilcoxon.

Results

Preliminary phytochemical analysis

The preliminary phytochemical analyses of EEZJ showed the presence of saponins, alkaloids, carbohydrates, proteins, and flavonoids and are outlinedin Chart 1.

Chart 1
Preliminary physicochemical studies of ethanolic extract of Ziziphus jujuba fruits.

Test	Observation
Nature and appearance	Semi solid, reddish Brown
Solubility	Soluble (water, ethanol, methanol), insoluble (toluene, acetone, benzene)
UV (EtOH) λ max	257, 314
IR spectra vmax at KBr	EZJ IR values: IR cm~ 3366 (-OH Stretch), 2927 (-CH stretch), 1733 (-C=O)
Phytochemicals present	Saponins (++), Alkaloids (++), Proteins (++), flavonoids (++), Triterpenoids (++), Tannins (++)

• (++) moderate; (+) mild.

Thin layer chromatography of EEZJ

The TLC profile clearly indicates the presence of four phytoconstituents (betulinic acid, oleanolic acid, betulin and lupeol) identified on the basis of color density: oleanolic acid (R_f 0.56) dark violet, betulinic acid (R_f 0.57) light violet, botulin (R_f 0.48) violet and lupeol (R_f 0.72) darker violet (Fig. 1A and 1B).

Fig. 1
A, TLC profile of ethanolic extract of Ziziphus jujubafruits. B, Rf value of phyto-constituents.

Acute toxicity study

EEZJ treatment up to 2000 mg/kg orally to mice did not induce mortality or clinical during 96 h observation period. Hence, LD₅₀ was considered to be more than 2000 mg/kg. Based on acute toxicity results, 250, 500 and 1000 mg/kg doses were selected for EEZJ of anti-allergy and anti-anaphylaxis studies.

Anti-allergic activity screening

Effect of EEZJ on milk induced eosinophilia, leukocytosis, and differential leukocytes count

Subcutaneous administration of full milk significantly elevated eosinophils, WBC's and differential leukocytes (neutrophils and monocytes) in rats. Pretreatment with EEZJ (500 mg/kg and 1000 mg/kg, p.o), dose dependently reduced milk induced eosinophilia, leukocytosis, monocytes, and neutrophils. Dexamethasone treatment showed a greater reduction of blood cells (Table 1).

Table 1
Effect of ethanolic extract of Ziziphus jujuba fruits on milk induced eosinophilia, leukocytosis and differential leukocytes in mice.

Treatment (mg/kg)	Eosinophilisper cu. mm (×10c/μl)a	Differential Leukocytes (×10c/μl)b		Total Leukocytes per cu. mmc
		Neutrophils	Monocytes
Normal control (NC)	68.88 ± 7.09	3.20 ± 0.40	33.4 ± 1.2	6120 ± 28.0
Induced control (IC)	158.80 ± 13.46	10.60 ± 0.84	48.4 ± 1.0	9920 ± 50.9
EZJ (250, p.o.)	120.20 ± 11.67	6.8 ± 0.8	44.2 ± 1.2	8890 ± 56.4
EZJ (500, p.o.)	102.00 ± 10.74	7.2 ± 0.6	38.3 ± 1.0	8690 ± 54.2
EZJ (1000, p.o.)	94. 00 ± 9.90	6.3 ± 0.8	34.3 ± 1.2	8420 ± 26.0
Dexamethasone (0.27, i.p.)	89.40 ± 7.71	6.1 ± 0.7+	32.8 ± 1.02	7980 ± 24

Effect of EEZJ on anaphylaxis (passive and active cutaneous) and compound 48/80 induced mast cell degranulation (in vivo)

Pretreatment with EEZJ the reduced dose dependently passive cutaneous reaction Pretreatment of sensitized rats with EEZJ and dexamethasone ameliorated anaphylactic reactions (decreased the respiratory score) determined by considering respiratory rate, dyspnea, cyanosis, and mortality due to challenge. Rats sensitized with compound 48/80 (1 mg/kg, s.c.), and subsequently treated with EEZJ produced dose dependent protection against mast cell degranulation due to the following challenge. Reference drug (ketotifen fumerate, 1 mg/kg, p.o.) treatment produced a greater protection against mast cell granulation than EEZJ (Table 2).

Table 2
Effect of ethanolic extract of Ziziphus jujuba fruits on anaphylaxis (passive and active cutaneous) and compound 48/80 induced mast cell degranulation (in vivo).

	Passive cutaneous anaphylaxis		Active anaphylaxis	Mast cell degranulation
Treatment (mg/kg, orally)	mm3 of blueing reaction	Onset of behavioral symptoms in min (% mortality)	Respiratory score (% mortality)	Intact	Degranulated (% protection)
Normal control (NC)	0	Normal	0 (0)	100	0
Induced control (IC)	76.35 ± 6.64	Respiratory distress/collapse, 3-5 min (70)	8.80 ± 7.70(60)	23.20 ± 2.51	76.80 ± 7.77
EZJ (250)	65.50 ± 5.74	Dyspnea, 4-8 min (40)	6.40 ± 4.55(50)	28.40 ± 2.52	71.60 ± 5.67(6.77)
EZJ (500)	59.38 ± 6.60	Dyspnea, 10-15 min (20)	5.20 ± 6.57(30)	35.60 ± 3.22	64.40 ± 6.72(16.14)
EZJ (1000)	54.35 ± 5.46	Normal (0)	2.40 ± 1.30(20)	43.20 ± 3.99	56.80 ± 4.60(26.04)
Dexamethasone (0.27)	46.40 ± 6.50	Normal (0)	2.00 ± 1.23(10)	-	-
Ketotifen (1)	-	-	-	60.40 ± 4.31	41.60 ± 2.53(45.83)

Effect of EEZJ on histamine and Ach induced contraction response of isolated guinea pig ileum and tracheal chain preparations respectively

Histamine elicited a dose dependent contraction in guinea pig ileum preparation and its responses were significantly inhibited in the presence of EEZJ and chlorpheniramine maleate. The IC₅₀ values of histamine responses is chlorpheniramine maleate [0.24 (0.22-0.26) µg/ml] and EEZJ [425 (350-510) µg/ml] were calculated. Acetylcholine produced dose dependent contraction in guinea pig tracheal chain preparation and its responses were dose dependently reduced in the presence of atropine and EEZJ maleate. The IC₅₀ values of Ach responses for atropine maleate [2.85 (2.6-3.4) ng/ml] and EEZJ [265 (241292) µg/ml] were calculated [Table 3].

Table 3
IC₅₀ values of histamine and Ach on isolated guinea pig ileum and tracheal chain preparations respectively.

	IC50 values of
Antagonist	Histamine response in the presence of antagonist in guinea pig ileum	Ach response in the presence of antagonist in guinea pig tracheal chain
Nil	16 (14.3-17.9) μg/ml [100 % contraction]	160 (145-176) μg/ml [100 % contraction]
Chlorpheniramine maleate	0.24 (0.22-0.26) μg/ml
Atropine maleate	-	2.85 (2.6-3.4) ng/ml
EZJ	425 (350-510) μg/ml	265 (241-292) μg/ml

Effect of EEZJ on serum IgE in rats

The antibody (IgE) formation was reduced at equally at both doses of EEZJ (500/1000 mg/kg) treatment. The effect may be due to the sealing effect of EEZJ at 500 mg/kg hence, increase in dose may not produce greater effect. The reduction of antibody formation by EEZJ (500/1000 mg/kg) was comparable to that of dexamethasone (0.27 mg/kg, i.p.) effect (Table 4).

Table 4
Effect of ethanolic extract of Ziziphus jujuba fruits on serum IgE antibodies in rats.

Treatment and dose	Serum IgE (μg/ml) on different days
	6	8	11
Albumin sensitized control group	4.3 ± 0.12	5.6 ± 0.2	7.8 ± 0.24
EZJ (500 mg/kg, p.o.)	4.0 ± 0.14	3.8 ± 0.1	4.3 ± 0.12
EZJ (1000 mg/kg, p.o.)	4.0 ± 0.11	3.4 ± 0.08	3.9 ± 0.1
Dexamethasone(0.27 mg/kg, p.o.)	3.4 ± 0.1	3.0 ± 0.1	3.6 ± 0.1

Effect of EEZJ on histamine induced hind paw edema in rats and inhibition Shultz-Dale reaction in guinea pig ileum (ex-vivo)

The injection of histamine into the sub plantar region of hind paw of rat induced an edema formation and edema was observed peak at 1 h. The rats pretreated with ibuprofen and EEZJ significantly inhibited paw edema formation at all intervals.

The EA induced contraction response on sensitized guinea pig ileum (ex vivo) was dose dependently inhibited d in the presence of EEZJ as well as disodium cromoglycate in the perfusate (Table 5).

Table 5
Effect of ethanolic extract of Ziziphus jujuba fruits on histamine induced hind paw edema in rats and inhibition Shultz-Dale reaction in guinea pig ileum (ex vivo).

Treatment (mg/kg, p.o.)	Paw edema (ml) at different time interval			Shultz-Dale reaction in guinea pig ileum (% inhibition)
	Initial	1 h	3 h	-	-	-
Normal control	0.85 ± 0.04	0.86 ± 0.05	0.86 ± 0.03	-
Induced control	0.87 ± 0.02	1.70 ± 0.08	1.60 ± 0.05	-	-	-
EZJ (500 mg/kg, p.o.)	0.83 ± 0.01	1.50 ± 0.03	1.42 ± 0.03	-	-	-
EZJ (1000 mg/kg, p.o.)	0.86 ± 0.03	1.32 ± 0.06	1.30 ± 0.02	-	-	-
Ibuprofen (50 mg/kg, p.o.)	0.87 ± 0.04	1.30 ± 0.03	1.26 ± 0.04	-	-	-
EZJ (20/50/100 μg/ml)	-	-	-	34 ± 3.6	54 ± 4.6	74 ± 6.4
Disodium chromoglycate(5/10/20 μg/ml)	-	-	-	51 ± 5.2	62 ± 5.6	76 ± 6.6

EA 10 mg/ml was taken as 100% contraction and compared with drug treated group.

Discussions

Eosinophils are distinguished phenotypically by their bilobed nuclei and large acidophilic cytoplasmic granules and participating also a major effector cells in allergy, asthma and airway function affect. Eosinophil degranulation is an important immunological event responsible for allergic cutaneous inflammation manifested in cow's milk. Therefore increased eosinophils reflect the overall state of allergic condition. This is supported by the fact that asthma/allergy patients show increased eosinophilia and leukocytosis (Horn et al., 1975; Noga et al., 2003) and can serve a sensitive cellular biomarker. The overall increased eosinophils and milk leukocytosis following administration may be due to the participation of bone marrow and T-cells derived lymphocytes (Lenon et al., 2007). During varied type of allergic manifestation, variety release inflammatory mediators (histamine, leukotrienes C4 and D4, cytokines and basic proteins) which provoke edema formation, vascular dilation and eosinophilic infiltration (Brigden, 1999; Justice et al., 2003). Prevented EEZJ treatment dose dependently cellular immune reactions,(like eosinophilia and leukocytosis) induced by milk in mice may have therapeutic implications in type-I hypersensitivity reaction and asthma.

The passive cutaneous anaphylaxis (PCA) and polybasic compound 48/80 induced allergic reaction is mediated by IgE mainly via increased vascular permeability and release of histamine from mast cells. EEZJ treatment prevented significantly IgE mediated allergic cutaneous and 48/80 induced systemic allergic reactions associated with inflammation and immune responses. Hence, it is believed EEZJ significant to exert anti-allergic activity in type-I IgE-mediated allergic skin reaction. Furthermore, prevention of degranulation of mast cells may be directly related to EEZJ formation by blocking effect on IgE sensitization phenomena through decreased membrane receptor interactions. Our findings are in agreement with the report that plant extract rich in flavonoids able to prevent IgE responses triggered anaphylactic shock (Dai et al., 2005; Kaneko et al., 2000). It is documented also that compound 40/80 increased permeability of the lipid bilayer membrane of membrane perturbation by causing could and trigger the release of mediators from the mast cells (Mousli et al., 1990). Such membrane based mechanism might be associated with chloride ion channel or may be responsible of elevation of intracellular cAMP might that provide driving force for calcium influx which may activate mast cells (Tasaka et al., 1986). Considering such complex cellular events in PCA and compound 48/80 IgE mediated type I allergic reactions, it is presumed that EEZJ exert inhibitory effect on multiple events eventually stabilize lipid membrane as well as G-protein activation, through intracellular Ca²⁺ release process (Han et al., 2007).

Experimental findings on isolated guinea pig tracheal chain and ileum suggest EEZJ property possesses anti-muscarinic and H₁ receptor antagonistic property. Further, inhibition of histamine induced paw edema indicates significant its antihistaminic activity. Hence it is presumed that such pharmacological properties of EEZJ may be responsible for amelioration of active anaphylactic reactions and improved survival rate (Pandit et al., 2008).

The major phytoconstituents of EEZJ are: triterpenoids (betulinic acid, betulin, lupeol), steroidal saponins (oleanolic acid), flavonoids, xylose and others (not identified), are known for antioxidant, cytotoxic, membrane stabilizing property, and also exert anti-asthmatic, anti-allergic, anti-complementary, immunomodulatory and anti-inflammatory, anti-anaphylactic activity and inhibit synthesis of IgE and/or cellular events of interaction with mast cell IgE receptors (Fu et al., 2011; Jin et al., 2011; Kovalenko et al., 2009). Other supporting reports are: coca enriched diet (polyphenols, 0.2% w/w) prevents synthesis of IgE in OVA induced allergic rat model (Abril-Gil et al., 2012), the leaf extract rich in the flavonols myricitrin decreased total IgE in an allergy model in transgenic mice (Shimosaki et al., 2011), and apple polyphenols are used in the prevention of seasonal allergy (Hirano et al., 2009; Wilson et al., 2010).

The mixture of Adhatoda vasica extract, plant Glycyrrhiza glabra, Solanum xanthocarpum, of Albizia lebbeck bark, and roots of Picrorhiza kurroa contains flavonoid, triterpenoids, steroidal saponins found to stabilize mast cell membrane and exhibit anti-asthmatic activity (Iyengar et al., 1994).

Conclusion

EEZJ exert potent anti-allergic activity via inhibition of a) IgE formation and b) chemical mediators released from mast cells by different mechanism(s) by there support traditional uses of Z. jujuba in the treatment of allergy related diseases. EEZJ can be developed to an anti-allergic herbal medicine by isolating active phytoconstituents individually or in combination and conducting clinical trials on human subjects to establish themselves its efficacy in the management of allergy and anaphylaxis.

Acknowledgment

Authors are thankful to Prof. Rahul Somani and Dr. K. S. Jain, Principal, SCOP for providing necessary facilities.

References

• Abril-Gil, M., Massot-Cladera, M., Perez-Cano, F.J., Castellote, C., Franch, A., Castell, M., 2012. A diet enriched with cocoa prevents IgE synthesis in a rat allergy model. Pharmacol Res 65, 603-608.
• Andhare, R.N., Raut, M.K., Naik, S.R., 2012. Evaluation of antiallergic and anti-anaphylactic activity of ethanolic extract of Sanseveiria trifasciata leaves (EEST) in rodents. J Ethnopharmacol. 142, 627-633.
• Bhargava, K.P., Singh, N., 1981. Anti-stress activity of Ocimum sanctum Linn. Indian J Med Res 73, 443-451.
• Bown, D., 1995. Encyclopaedia of Herbs and their Uses. Dorling Kindersley, London.
• Brigden, M.L., 1999. Eosinophilia. Postgraduate Med 3, 105-115.
• Cavalher-Machado, S.C., Rosas, E.C., Brito Fde, A., Heringe, A.P., de Oliveira, R.R., Kaplan, M.A., Figueiredo, M.R., Henriques, M., 2008. The anti-allergic activity of the acetate fraction of Schinus terebinthifolius leaves in IgE induced mice paw edema and pleurisy. Int. Immunopharmacol. 8, 1552-1560.
• Chaudhari, K.N., Lahiri, C., 1974. Role of goat trachea for an isolated tracheal chain preparation. Indian J. Pharmacol. 6, 957-966.
• Dai, Y., But, P.P.H., Chu, L.M., Chan, Y.P., 2005. Inhibitory effects of Selaginella tamariscina on immediate allergic reactions. Am. J. Chinese Med. 33, 957-966.
• Fu, J.Y., Qian, L.B., Zhu, L.G., Liang, H.T., Tan, Y.N., Lu, H.T., Lu, J.F., Wang, H.P., Xia, Q., 2011. Betulinic acid ameliorates endothelium-dependent relaxation in L-NAME-induced hypertensive rats by reducing oxidative stress. Eur. J. Pharm. Sci. 44, 385-391.
• Gao, Q.H., Wu, C.S., Wang, M., 2013. The jujube (Ziziphus jujuba Mill.) fruit: a review of current knowledge of fruit composition and health benefits. J. Agr. Food Chem. 61, 3351-3363.
• Gautam, A.M., Ali, A.A., Gupta, P.P., Kar, K., 1989. Methoxyvsicinone (compound 73/602): a Potentially orally active anti-allergic agent. Indian J. Allegy Appl. Immunol. 3, 13-19.
• Gul, J., Mir, A.K., Farzana, G., 2009. Ethno medicinal plants used against jaundice in Dir Kohistan Valleys (NWFP), Pakistan. Ethnobot Leaflets. 13, 1029-1041.
• Han, S.J., Bae, E.A., Trinh, H.T., Yang, J.H., Youn, U.J., Bae, K.H., Kim, D.H., 2007. Magnolol and honokiol: inhibitors against mouse passive cutaneous anaphylaxis reaction and scratching behaviors. Biol. Pharm. Bull. 30, 2201-2203.
• Him-Che, Y., 1985. Handbook of Chinese Herbs and Formulas. Institute of Chinese Medicine.
• Hirano, T., Kawai, M., Arimitsu, J., Ogawa, M., Kuwahara, Y., Hagihara, K., Shima, Y., Narazaki, M., Ogata, A., Koyanagi, M., Kai, T., Shimizu, R., Moriwaki, M., Suzuki, Y., Ogino, S., Kawase, I., Tanaka, T., 2009. Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis. Allergology Int. 58, 373-382.
• Holsapple, M.P., Schnur, M., Yim, G.K., 1980. Pharmacological modulation of edema mediated by prostaglandin, serotonin and histamine. Agents Actions. 10, 368-373.
• Horn, B.R., Robin, E.D., Theodore, J., Van Kessel, A., 1975. Total eosinophil counts in the management of bronchial asthma. New England J. Med. 292, 1152-1155.
• Iyengar, M.A., Jambiah, K., Rao, G.M., Kamath, M.S., 1994. Studies on antiasthma kadha: a proprietary herbal combination; Part II - pharmacological studies. Indian Drugs. 31, 187-191.
• Jin, C., Shelburne, C. P., Li, G.J., Potts, E.N., Riebe, K.J., Sempowski, G.D., Foster, W.M., Abraham, S.N., 2011. Particulate allergens potentiate allergic asthma in mice through sustained IgEmediated mast cell activation. J. Clin. Invest. 121, 941-955.
• Justice, J.P., Borchers, M.T., Crosby, J.R., Hines, E.M., Shen, H.H.H., Ochkur, S.I., McGarry, M.P., Lee, N.A., Lee, J.J., 2003. Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology. Am. J. Physiol-Lung C. 284, L169-L178.
• Kalesnikoff, J., Galli, S.J., 2008. New developments in mast cell biology. Nat. Immunol. 9, 1215-1223.
• Kaneko, M., A., S., Gleich, G.J., Kita, H., 2000. Ligation of IgE receptor causes as anaphylactic response and neutrophil infiltration but does not induces eosinophilic inflammation in mice. J. Allergy Clin. Immunol. 105, 1202-1210.
• Kovalenko, L.P., Shipaeva, E.V., Balakshin, V.V., Presnova, G.A., Chistyakov, A.N., Klodt, P.M., Kudrin, V.S., Durnev, A.D., 2009. Antiallergenic activity of birch bark dry extract with at least 70% betulin content. Pharm. Chem. J. 43, 110-114.
• Lenon, G.B., Li, C.G., Xue, C.C., Thien, F.C.K., Story, D.F., 2007. Inhibition of release of vasoactive and inflammatory mediators in airway and vascular tissues and macrophages by a Chinese herbal medicine formula for allergic rhinitis. Evid-Based Compl. Alt. 4, 209-217.
• Mitra, S.K., Gopumadhavan, S., Venkataranganna, M.V., Anturlikar, S.D., 1999. Anti-asthmatic and anti-anaphylactic effect of E-721B, a herbal formulation. Indian J. Pharmacol. 31, 133-137.
• Mousli, M., Bronner, C., Bockaert, J., Rouot, B., Landry, Y., 1990. Interaction of substance-P, compound-48/80 and mastoparan with the alpha-subunit C-terminus of G-protein. Immunol. Lett. 25, 355-357.
• Noga, O., Hanf, G., Kunkel, G., 2003. Immunological and clinical changes in allergic asthmatics following treatment with omalizumab. Int. Arch. Allergy Imm. 131, 46-52.
• Pandit, P., Singh, A., Bafna, A.R., Kadam, P.V., Patil, M.J., 2008. Evaluation of antiasthmatic activity of Curculigo orchioides Gaertn. rhizomes. Indian J. Pharm. Sci. 70, 440-444.
• Saif, M.W., Lansigan, F., Ruta, S., Lamb, L., Mezes, M., Elligers, K., Grant, N., Jiang, Z.L., Liu, S.H., Cheng, Y.C., 2010. Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies. Phytomedicine. 17, 161-169.
• Shimosaki, S., Tsurunaga, Y., Itamura, H., Nakamura, M., 2011. Anti-allergic effect of the flavonoid myricitrin from Myrica rubra leaf extracts in vitro and in vivo. Nat. Prod. Res. 25, 374-380.
• Tasaka, K., Mio, M., Okamoto, M., 1986. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann. Allergy. 56, 464-469.
• Wilson, D., Evans, M., Guthrie, N., Sharma, P., Baisley, J., Schonlau, F., Burki, C., 2010. A randomized, double-blind, placebo-controlled exploratory study to evaluate the potential of pycnogenol (R) for improving allergic rhinitis symptoms. Phytother Res. 24, 1115-1119.
• Xie, H., He, S.H., 2005. Roles of histamine and its receptors in allergic and inflammatory bowel diseases. World J. Gastroentero. 11, 2851-2857.

Publication Dates

• Publication in this collection
  Sep-Oct 2013

History

• Received
  20 Aug 2013
• Accepted
  06 Oct 2013